As of 2025-05-31, the Relative Valuation of Vitaspring Biomedical Co. Ltd (VSBC) is 0.06 USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.00 USD, the upside of Vitaspring Biomedical Co. Ltd based on Relative Valuation is -94.2%.
The range of the Relative Valuation is 0.04 - 0.11 USD.
| Range | Selected | |
| Trailing P/E multiples | 6.0x - 6.8x | 6.4x |
| Forward P/E multiples | 8.1x - 20.5x | 14.3x |
| Fair Price | 0.04 - 0.11 | 0.06 |
| Upside | -96.5% - -88.6% | -94.2% |
| Date | P/E |
| 2025-03-05 | 170.36 |
| 2025-03-04 | 170.36 |
| 2025-02-26 | 34.07 |
| 2025-02-19 | 30.66 |